Publications
198
Citations
9,946
Est. group size
~19
Recurring co-author estimate
Active years
43
Publishing since 1984
Vincenzo Coppola's research focuses on the molecular biology of cancer, particularly how mitochondrial transport proteins and cell-cycle regulators (such as Cdk2 and Cyclin A2) contribute to tumor growth and metabolism. Recent work also explores genome engineering tools, including 'safe harbor' sites in the human genome for inserting new genetic material, and mitochondrial transporters in pancreatic cancer. The lab uses a mix of molecular, genetic, and yeast-model approaches to study these cancer-related mechanisms.
Publication output has been relatively steady over most of the past decade (roughly 6-13 per year) with a pronounced spike in 2023, followed by a decline in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Human Genome Safe Harbor Sites: A Comprehensive Review of Criteria, Discovery, Features, and Applications
Cells · 2026
- The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives
International Journal of Molecular Sciences · 2024
- Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review
Cancers · 2023
- Generation of a Yeast Cell Model Potentially Useful to Identify the Mammalian Mitochondrial N-Acetylglutamate Transporter
Biomolecules · 2023
- Supplementary Figure 2 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 8 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 4 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure Legends from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 6 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 7 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 1 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 5 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 3 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 8 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Supplementary Figure 7 from Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis
2023
- Cancer Research×11
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Nature Communications×7
- Proceedings of the National Academy of Sciences×4
- The Journal of Experimental Medicine×3
- Swetha Rajasekaran
Medicine · The Ohio State University
- Lindsey D. Mayo
Medicine · Indiana University
- Jian Zhu
Medicine · The Ohio State University
- Anna E. Vilgelm
Medicine · The Ohio State University
- Bhavneet Singh
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile